ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice
about
Animal models for thrombotic thrombocytopenic purpuraLesion Size Is Exacerbated in Hypoxic Rats Whereas Hypoxia-Inducible Factor-1 Alpha and Vascular Endothelial Growth Factor Increase in Injured Normoxic Rats: A Prospective Cohort Study of Secondary Hypoxia in Focal Traumatic Brain InjuryADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpuraAllosteric activation of ADAMTS13 by von Willebrand factor.Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.Experiences in a family with the Upshaw-Schulman syndrome over a 44-year period.ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review.Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpuraReduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease.ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in miceHigh-resolution molecular imaging via intravital microscopy: illuminating vascular biology in vivo.Structure-function and regulation of ADAMTS-13 protease.von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage.VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice.ADAMTS13, TTP and Beyondvon Willebrand factor: the old, the new and the unknown.Molecular biology of atherosclerosis.On the versatility of von Willebrand factorPlatelets and von Willebrand factor in atherogenesis.von Willebrand factor and inflammation.A method for the automated processing and analysis of images of ULVWF-platelet strings.Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism.Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study.Thrombus Formation and Propagation in the Onset of Cardiovascular Events
P2860
Q26851228-15C76543-5052-401D-8BB7-3E747E695B6AQ27318424-321673E9-6BAD-41F4-A02C-BE0484074C5EQ28083264-883AF84D-A4A9-4C05-B787-FFF319BA8013Q29568910-95DC2017-A540-4F7B-92CC-D4B7EEE23D96Q33402998-E7357612-FEA4-47FE-9785-B4F52F46DE34Q33409258-1489800E-234E-4D56-A9C8-A8F458801635Q33423350-0FDF8BB4-6D19-4672-890B-B9F7B6EF622BQ33430254-30A9855D-45E0-4259-AD9F-2233B13F0319Q33435545-D8E807B4-3909-47D5-B4DE-31154DDECE6FQ33773324-3A9F423F-ED27-4B6E-A58B-3F87AE37D9D5Q33883043-A85F10C3-F6F0-4477-83A9-018169798960Q35607298-60EF6DF8-311F-4467-B328-4CC676D5B3B0Q36091783-65038B06-0F4F-4D5B-AE77-CBDEA34255DBQ36166160-61DA2C90-582F-44FF-B403-8ACBD06C3E59Q36174498-1484C162-E388-41DF-A5BF-1CCC11AAB647Q36179343-2ED91634-DDB6-4FF0-83C0-072B19E22C88Q36201783-57F40F8F-A2C6-42B0-B005-43DCE8B2F5BDQ36509653-B87DE723-FB1D-40BE-998A-CE640277ED63Q36509659-77247A9B-0988-4C49-B698-DBA90C5F34B7Q36572425-EEB2D10E-741C-4189-BB7A-B3B83876EA2BQ37019574-85FF9227-127F-4999-8B39-1710A0BE993CQ37366918-7EC6A5F6-7035-465E-B20F-262C55D4D2EEQ37429699-29867903-54A4-4990-85D7-E144DF739543Q37725685-9667E42A-5BD7-4128-9CF6-C1ED211129C5Q38047344-6D39EC0A-B802-453B-BBE0-455C274B19F2Q38125279-7180C957-84C7-4B4B-9719-C0ABF92A95E1Q38128303-282CEA51-0278-4B7D-829F-958D2059D659Q39125083-65A71966-AB93-4B64-832B-17BC78D0ED7CQ39410942-97A4C797-3008-4CEA-A33B-BC2648C4123EQ47434741-43F0D564-745A-4DAB-8910-98BE19EC9765Q47551614-2978239E-D7FA-48A4-AD49-D49306EB58B1Q50483202-89E73EB9-9972-4BF9-B767-69D3944A0FCDQ55318125-BB952AE7-AB43-42A5-8A5B-A6FF10C3600FQ58805706-E94B8CE9-C32C-4BBF-956B-196A21F91EE5
P2860
ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@ast
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@en
type
label
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@ast
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@en
prefLabel
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@ast
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@en
P2093
P2860
P1433
P1476
ADAMTS13 reduces vascular infl ...... early atherosclerosis in mice
@en
P2093
Anil K Chauhan
Chintan Gandhi
Mohammad Moshahid Khan
Steven R Lentz
P2860
P304
P356
10.1182/BLOOD-2011-09-376202
P407
P577
2011-11-28T00:00:00Z